20 likes | 35 Views
Europe minimal residual disease (MRD) testing market was valued at $ 265.6 million in 2021.<br> Europe minimal residual disease this comprehensive study of MRD testing patterns shows <br>consistent practice across France, Germany, Italy, Spain, and the UK with respect to the<br> timing and frequency of MRD testing, Europe minimal residual disease aligning with use of<br> national protocols. Premium primary and secondary information sources with inputs derived from<br> industry professionals across the value chain.<br>https://www.thepiresearch.com/
E N D